← RxSight, Inc. RXST
Market Price
$6.90
Market Cap
$273.22M
P/E Ratio
N/A
Revenue (FY 2025)
↓-3.9% YoY
$134.48M
3-Yr CAGR: 40.0%
Net Income
↓-41.8% YoY
-$38.94M
Net Margin: -29.0%
Free Cash Flow
↑13.6% YoY
-$19.34M
FCF Yield: -7.08%
EPS (Diluted)
↓-33.8% YoY
$-0.95
Basic: $-0.95
Return on Equity
Efficiency
-14.1%
ROA: -12.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (RXST)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2020 | $14.7M | — | $1.7M | $27.6M | — | $0.15 | — | $-35.2M | $-37.7M | — |
| FY 2021 | $22.6M | +53.9% | $4.5M | $-48.7M | -276.6% | $-3.57 | -2,480.0% | $-44.7M | $-46.6M | -23.6% |
| FY 2022 | $49.0M | +116.9% | $21.3M | $-66.8M | -37.1% | $-2.41 | +32.5% | $-58.9M | $-61.2M | -31.3% |
| FY 2023 | $89.1M | +81.8% | $53.8M | $-48.6M | +27.2% | $-1.41 | +41.5% | $-41.6M | $-46.4M | +24.2% |
| FY 2024 | $139.9M | +57.1% | $98.9M | $-27.5M | +43.5% | $-0.71 | +49.6% | $-16.9M | $-22.4M | +51.8% |
| FY 2025 | $134.5M | -3.9% | $103.0M | $-38.9M | -41.8% | $-0.95 | -33.8% | $-15.5M | $-19.3M | +13.6% |
Valuation
Market Price
$6.90
Market Cap
$273.22M
Enterprise Value
$274.19M
P/E Ratio
N/A
P/B Ratio
1.04
FCF Yield
-7.08%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
76.60%
Operating Margin
-35.84%
Net Margin
-28.96%
Return on Equity (ROE)
-14.13%
Return on Assets (ROA)
-12.49%
Asset Turnover
0.43x
Revenue 3-Yr CAGR
40.00%
Financial Health & Liquidity
Current Ratio
0.22
Cash Ratio
1.01
Debt / Equity
0.076
Debt / Assets
0.067
Cash & Equivalents
$19.95M
Total Debt
$20.92M
Book Value / Share
$6.63
Cash Flow Efficiency
Operating Cash Flow
-$15.51M
Capital Expenditures (CapEx)
$3.83M
Free Cash Flow
-$19.34M
OCF / Revenue
-11.53%
FCF / Revenue
-14.38%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-0.95
EPS (Basic)
$-0.95
Dividends / Share
N/A
Book Value / Share
$6.63
EPS YoY Growth
-33.80%
Balance Sheet (FY 2025)
Total Assets
$311.81M
Total Liabilities
$311.81M
Stockholders' Equity
$275.68M
Current Assets
$4.39M
Current Liabilities
$19.80M